Λεβοφλοξασίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Λεβοφλοξασίνη" in Greek language version.

refsWebsite

Global rank Greek rank

48nih.gov

4^th place

36doi.org

2^nd place

3^rd place

9web.archive.org

1^st place

6archive.org

6^th place

5^th place

4drugs.com

399^th place

130^th place

4fda.gov

447^th place

368^th place

3books.google.com

3^rd place

6^th place

2clincalc.com

3,912^th place

594^th place

2asm.org

3,555^th place

2,131^st place

1chemsrc.com

low place

1rero.ch

3,510^th place

low place

1europa.eu

68^th place

24^th place

1cdc.gov

218^th place

156^th place

1worldcat.org

5^th place

8^th place

1oxfordjournals.org

1,389^th place

724^th place

1gov.uk

432^nd place

530^th place

archive.org

«Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders». Pediatr. Infect. Dis. J. 26 (10): 879–91. October 2007. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792. https://archive.org/details/sim_pediatric-infectious-disease-journal_2007-10_26_10/page/879.
«In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin». Antimicrob. Agents Chemother. 36 (4): 860–6. April 1992. doi:10.1128/aac.36.4.860. PMID 1503449. PMC 189464. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1992-04_36_4/page/860.
«Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone». Antimicrob. Agents Chemother. 41 (1): 204–11. January 1997. doi:10.1128/AAC.41.1.204. PMID 8980783. PMC 163688. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1997-01_41_1/page/204.
«Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding». Clin. Pharmacol. Ther. 84 (5): 581–8. November 2008. doi:10.1038/clpt.2008.150. PMID 18685566. PMC 2574587. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2008-11_84_5/page/581.
«Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide». Antimicrob. Agents Chemother. 37 (10): 2173–8. October 1993. doi:10.1128/aac.37.10.2173. PMID 8257141. PMC 192246. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1993-10_37_10/page/2173.
«Fluoroquinolone toxicity profiles: a review focusing on newer agents». Clin. Infect. Dis. 28 (2): 352–64. February 1999. doi:10.1086/515104. PMID 10064255. https://archive.org/details/sim_clinical-infectious-diseases_1999-02_28_2/page/352.

asm.org

mmbr.asm.org

«DNA gyrase, topoisomerase IV, and the 4-quinolones». Microbiol Mol Biol Rev 61 (3): 377–92. 1 September 1997. doi:10.1128/.61.3.377-392.1997. PMID 9293187. PMC 232616. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=9293187.

aac.asm.org

Morrissey, I.; Hoshino, K.; Sato, K.; Yoshida, A.; Hayakawa, I.; Bures, MG.; Shen, LL. (August 1996). «Mechanism of differential activities of ofloxacin enantiomers». Antimicrob Agents Chemother 40 (8): 1775–84. doi:10.1128/AAC.40.8.1775. PMID 8843280. PMC 163416. Αρχειοθετήθηκε από το πρωτότυπο στις 11 June 2011. https://web.archive.org/web/20110611220904/http://aac.asm.org/cgi/reprint/40/8/1775.pdf.

books.google.com

Yaffe, Gerald G. Briggs, Roger K. Freeman, Sumner J. (2011). Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk (9th έκδοση). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. σελ. 828. ISBN 9781608317080.
Fischer, Jnos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. σελ. 500. ISBN 9783527607495.
Walter Sneader (31 Οκτωβρίου 2005). Drug Discovery: A History. John Wiley & Sons. σελ. 295. ISBN 978-0-470-01552-0.

cdc.gov

CDC. «Antibiotic Resistance Threats in the United States, 2013» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 17 Νοεμβρίου 2014.

chemsrc.com

«Levofloxacin_msds».

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Levofloxacin - Drug Usage Statistics». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections». Treat Respir Med 5 (6): 437–65. 2006. doi:10.2165/00151829-200605060-00009. PMID 17154673.
«Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults». Clin. Infect. Dis. 44 Suppl 2: S27–72. March 2007. doi:10.1086/511159. PMID 17278083.
File TM (August 2010). «Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines». Clin. Infect. Dis. 51 Suppl 1: S42–7. doi:10.1086/653048. PMID 20597671.
«Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America». Clin. Infect. Dis. 50 (5): 625–63. March 2010. doi:10.1086/650482. PMID 20175247.
«Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America». Clin. Infect. Dis. 50 (2): 133–64. January 2010. doi:10.1086/649554. PMID 20034345.
«Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America». Clin. Infect. Dis. 56 (1): 1–10. January 2013. doi:10.1093/cid/cis966. PMID 23230301. http://doc.rero.ch/record/302350/files/cis966.pdf.
Schaeffer AJ (September 2004). «NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis». Int. J. Antimicrob. Agents 24 Suppl 1: S49–52. doi:10.1016/j.ijantimicag.2004.02.009. PMID 15364307.
«Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery». Cochrane Database Syst Rev 2: CD006364. 2017. doi:10.1002/14651858.CD006364.pub3. PMID 28192644.
«Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis». Pharm. Res. 35 (5): 109. March 2018. doi:10.1007/s11095-018-2383-8. PMID 29582196.
«The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America». Clin. Infect. Dis. 53 (7): e25–76. 2011. doi:10.1093/cid/cir531. PMID 21880587.
«Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders». Pediatr. Infect. Dis. J. 26 (10): 879–91. October 2007. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792. https://archive.org/details/sim_pediatric-infectious-disease-journal_2007-10_26_10/page/879.
«Fluoroquinolones in the management of community-acquired pneumonia in primary care». Expert Rev Anti Infect Ther 8 (11): 1259–71. November 2010. doi:10.1586/eri.10.110. PMID 21073291.
«Induction of resistance of Streptococcus pneumoniae to quinolones in vitro». Chemotherapy 39 (1): 36–9. 1993. doi:10.1159/000238971. PMID 8383031.
«In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin». Antimicrob. Agents Chemother. 36 (4): 860–6. April 1992. doi:10.1128/aac.36.4.860. PMID 1503449. PMC 189464. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1992-04_36_4/page/860.
Blondeau JM (May 1999). «A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'». J. Antimicrob. Chemother. 43 Suppl B (90002): 1–11. doi:10.1093/jac/43.suppl_2.1. PMID 10382869.
«Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone». Antimicrob. Agents Chemother. 41 (1): 204–11. January 1997. doi:10.1128/AAC.41.1.204. PMID 8980783. PMC 163688. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1997-01_41_1/page/204.
John A. Bosso (1998). «New and Emerging Quinolone Antibiotics». Journal of Infectious Disease Pharmacotherapy 2 (4): 61–76. doi:10.1300/J100v02n04_06. ISSN 1068-7777.
Hawkey, PM (May 2003). «Mechanisms of quinolone action and microbial response.». The Journal of Antimicrobial Chemotherapy 51 Suppl 1 (90001): 29–35. doi:10.1093/jac/dkg207. PMID 12702701.
«Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes». Acta Pharmacol. Sin. 29 (12): 1507–14. December 2008. doi:10.1111/j.1745-7254.2008.00908.x. PMID 19026171.
«Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding». Clin. Pharmacol. Ther. 84 (5): 581–8. November 2008. doi:10.1038/clpt.2008.150. PMID 18685566. PMC 2574587. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2008-11_84_5/page/581.
Domagala JM (April 1994). «Structure-activity and structure-side-effect relationships for the quinolone antibacterials». J. Antimicrob. Chemother. 33 (4): 685–706. doi:10.1093/jac/33.4.685. PMID 8056688. Αρχειοθετήθηκε από το πρωτότυπο στις 25 February 2009. https://web.archive.org/web/20090225032553/http://jac.oxfordjournals.org/cgi/reprint/33/4/685.
«New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety». Clin. Infect. Dis. 17 Suppl 1: S192–9. August 1993. doi:10.1093/clinids/17.supplement_1.s192. PMID 8399914.
«Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide». Antimicrob. Agents Chemother. 37 (10): 2173–8. October 1993. doi:10.1128/aac.37.10.2173. PMID 8257141. PMC 192246. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1993-10_37_10/page/2173.
«Tendon Injury and Fluoroquinolone Use: A Systematic Review». Drug Saf 36 (9): 709–21. September 2013. doi:10.1007/s40264-013-0089-8. PMID 23888427.
«Fluoroquinolone-associated tendinopathy: a critical review of the literature». Clin. Infect. Dis. 36 (11): 1404–10. June 2003. doi:10.1086/375078. PMID 12766835.
«Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review». Drug Saf 34 (10): 839–47. October 2011. doi:10.2165/11593110-000000000-00000. PMID 21879778.
Hall, MM; Finnoff, JT; Smith, J (February 2011). «Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population.». PM&R : The Journal of Injury, Function, and Rehabilitation 3 (2): 132–42. doi:10.1016/j.pmrj.2010.10.003. PMID 21333952.
Carbon C (2001). «Comparison of side effects of levofloxacin versus other fluoroquinolones». Chemotherapy 47 Suppl 3 (3): 9–14; discussion 44–8. doi:10.1159/000057839. PMID 11549784.
Liu HH (May 2010). «Safety profile of the fluoroquinolones: focus on levofloxacin». Drug Saf 33 (5): 353–69. doi:10.2165/11536360-000000000-00000. PMID 20397737.
«Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials». CMAJ 178 (7): 845–54. March 2008. doi:10.1503/cmaj.071157. PMID 18362380.
«Fluoroquinolone toxicity profiles: a review focusing on newer agents». Clin. Infect. Dis. 28 (2): 352–64. February 1999. doi:10.1086/515104. PMID 10064255. https://archive.org/details/sim_clinical-infectious-diseases_1999-02_28_2/page/352.
«Risks associated with the therapeutic use of fluoroquinolones». Expert Opin Drug Saf 12 (4): 497–505. July 2013. doi:10.1517/14740338.2013.796362. PMID 23651367.
«DNA gyrase, topoisomerase IV, and the 4-quinolones». Microbiol Mol Biol Rev 61 (3): 377–92. 1 September 1997. doi:10.1128/.61.3.377-392.1997. PMID 9293187. PMC 232616. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=9293187.
McGregor, JC; Allen, GP; Bearden, DT (October 2008). «Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.». Therapeutics and Clinical Risk Management 4 (5): 843–53. doi:10.2147/TCRM.S3426. PMID 19209267.
Morrissey, I.; Hoshino, K.; Sato, K.; Yoshida, A.; Hayakawa, I.; Bures, MG.; Shen, LL. (August 1996). «Mechanism of differential activities of ofloxacin enantiomers». Antimicrob Agents Chemother 40 (8): 1775–84. doi:10.1128/AAC.40.8.1775. PMID 8843280. PMC 163416. Αρχειοθετήθηκε από το πρωτότυπο στις 11 June 2011. https://web.archive.org/web/20110611220904/http://aac.asm.org/cgi/reprint/40/8/1775.pdf.
Kannappan, Valliappan; Mannemala, Sai Sandeep (7 June 2014). «Multiple Response Optimization of a HPLC Method for the Determination of Enantiomeric Purity of S-Ofloxacin». Chromatographia 77 (17–18): 1203–1211. doi:10.1007/s10337-014-2699-4.

drugs.com

«Levofloxacin Use During Pregnancy». Drugs.com. 7 Ιανουαρίου 2019. Ανακτήθηκε στις 13 Σεπτεμβρίου 2020.
«Levofloxacin ophthalmic Use During Pregnancy». Drugs.com. 11 Μαρτίου 2020. Ανακτήθηκε στις 13 Σεπτεμβρίου 2020.
«Levofloxacin». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαΐου 2016. Ανακτήθηκε στις 25 Αυγούστου 2016.
«Levofloxacin ophthalmic medical facts from Drugs.com». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Φεβρουαρίου 2017. Ανακτήθηκε στις 23 Ιανουαρίου 2017.

europa.eu

ecdc.europa.eu

ECDC (2014). «Antimicrobial resistance surveillance in Europe 2014» (PDF). Αρχειοθετήθηκε από το πρωτότυπο στις 14 Απριλίου 2016.

fda.gov

FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions. Δελτίο τύπου.
«FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling adverse effects that can occur». US Department of Health and Human Services. 25 Αυγούστου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Αυγούστου 2016.

accessdata.fda.gov

«US Label» (PDF). 2016. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 19 Σεπτεμβρίου 2016.
«STATISTICAL REVIEW AND EVALUATION» (PDF). USA: FDA. 21 Νοεμβρίου 1996. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 18 Οκτωβρίου 2012.

gov.uk

«Fluoroquinolone antibiotics: New restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects».

nih.gov

ncbi.nlm.nih.gov

«A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections». Treat Respir Med 5 (6): 437–65. 2006. doi:10.2165/00151829-200605060-00009. PMID 17154673.
«Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults». Clin. Infect. Dis. 44 Suppl 2: S27–72. March 2007. doi:10.1086/511159. PMID 17278083.
File TM (August 2010). «Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines». Clin. Infect. Dis. 51 Suppl 1: S42–7. doi:10.1086/653048. PMID 20597671.
«Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America». Clin. Infect. Dis. 50 (5): 625–63. March 2010. doi:10.1086/650482. PMID 20175247.
«Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America». Clin. Infect. Dis. 50 (2): 133–64. January 2010. doi:10.1086/649554. PMID 20034345.
«Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America». Clin. Infect. Dis. 56 (1): 1–10. January 2013. doi:10.1093/cid/cis966. PMID 23230301. http://doc.rero.ch/record/302350/files/cis966.pdf.
Schaeffer AJ (September 2004). «NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis». Int. J. Antimicrob. Agents 24 Suppl 1: S49–52. doi:10.1016/j.ijantimicag.2004.02.009. PMID 15364307.
«Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery». Cochrane Database Syst Rev 2: CD006364. 2017. doi:10.1002/14651858.CD006364.pub3. PMID 28192644.
«Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis». Pharm. Res. 35 (5): 109. March 2018. doi:10.1007/s11095-018-2383-8. PMID 29582196.
«The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America». Clin. Infect. Dis. 53 (7): e25–76. 2011. doi:10.1093/cid/cir531. PMID 21880587.
«Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders». Pediatr. Infect. Dis. J. 26 (10): 879–91. October 2007. doi:10.1097/INF.0b013e3180cbd382. PMID 17901792. https://archive.org/details/sim_pediatric-infectious-disease-journal_2007-10_26_10/page/879.
«Fluoroquinolones in the management of community-acquired pneumonia in primary care». Expert Rev Anti Infect Ther 8 (11): 1259–71. November 2010. doi:10.1586/eri.10.110. PMID 21073291.
«Induction of resistance of Streptococcus pneumoniae to quinolones in vitro». Chemotherapy 39 (1): 36–9. 1993. doi:10.1159/000238971. PMID 8383031.
«In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin». Antimicrob. Agents Chemother. 36 (4): 860–6. April 1992. doi:10.1128/aac.36.4.860. PMID 1503449. PMC 189464. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1992-04_36_4/page/860.
Blondeau JM (May 1999). «A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'». J. Antimicrob. Chemother. 43 Suppl B (90002): 1–11. doi:10.1093/jac/43.suppl_2.1. PMID 10382869.
«Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone». Antimicrob. Agents Chemother. 41 (1): 204–11. January 1997. doi:10.1128/AAC.41.1.204. PMID 8980783. PMC 163688. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1997-01_41_1/page/204.
Hawkey, PM (May 2003). «Mechanisms of quinolone action and microbial response.». The Journal of Antimicrobial Chemotherapy 51 Suppl 1 (90001): 29–35. doi:10.1093/jac/dkg207. PMID 12702701.
«Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes». Acta Pharmacol. Sin. 29 (12): 1507–14. December 2008. doi:10.1111/j.1745-7254.2008.00908.x. PMID 19026171.
«Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding». Clin. Pharmacol. Ther. 84 (5): 581–8. November 2008. doi:10.1038/clpt.2008.150. PMID 18685566. PMC 2574587. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2008-11_84_5/page/581.
Domagala JM (April 1994). «Structure-activity and structure-side-effect relationships for the quinolone antibacterials». J. Antimicrob. Chemother. 33 (4): 685–706. doi:10.1093/jac/33.4.685. PMID 8056688. Αρχειοθετήθηκε από το πρωτότυπο στις 25 February 2009. https://web.archive.org/web/20090225032553/http://jac.oxfordjournals.org/cgi/reprint/33/4/685.
«New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety». Clin. Infect. Dis. 17 Suppl 1: S192–9. August 1993. doi:10.1093/clinids/17.supplement_1.s192. PMID 8399914.
«Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide». Antimicrob. Agents Chemother. 37 (10): 2173–8. October 1993. doi:10.1128/aac.37.10.2173. PMID 8257141. PMC 192246. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1993-10_37_10/page/2173.
«Tendon Injury and Fluoroquinolone Use: A Systematic Review». Drug Saf 36 (9): 709–21. September 2013. doi:10.1007/s40264-013-0089-8. PMID 23888427.
«Fluoroquinolone-associated tendinopathy: a critical review of the literature». Clin. Infect. Dis. 36 (11): 1404–10. June 2003. doi:10.1086/375078. PMID 12766835.
Kim GK (April 2010). «The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?». J Clin Aesthet Dermatol 3 (4): 49–54. PMID 20725547.
«Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review». Drug Saf 34 (10): 839–47. October 2011. doi:10.2165/11593110-000000000-00000. PMID 21879778.
Hall, MM; Finnoff, JT; Smith, J (February 2011). «Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population.». PM&R : The Journal of Injury, Function, and Rehabilitation 3 (2): 132–42. doi:10.1016/j.pmrj.2010.10.003. PMID 21333952.
Carbon C (2001). «Comparison of side effects of levofloxacin versus other fluoroquinolones». Chemotherapy 47 Suppl 3 (3): 9–14; discussion 44–8. doi:10.1159/000057839. PMID 11549784.
Liu HH (May 2010). «Safety profile of the fluoroquinolones: focus on levofloxacin». Drug Saf 33 (5): 353–69. doi:10.2165/11536360-000000000-00000. PMID 20397737.
«Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials». CMAJ 178 (7): 845–54. March 2008. doi:10.1503/cmaj.071157. PMID 18362380.
«Fluoroquinolone toxicity profiles: a review focusing on newer agents». Clin. Infect. Dis. 28 (2): 352–64. February 1999. doi:10.1086/515104. PMID 10064255. https://archive.org/details/sim_clinical-infectious-diseases_1999-02_28_2/page/352.
«Risks associated with the therapeutic use of fluoroquinolones». Expert Opin Drug Saf 12 (4): 497–505. July 2013. doi:10.1517/14740338.2013.796362. PMID 23651367.
«DNA gyrase, topoisomerase IV, and the 4-quinolones». Microbiol Mol Biol Rev 61 (3): 377–92. 1 September 1997. doi:10.1128/.61.3.377-392.1997. PMID 9293187. PMC 232616. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=9293187.
McGregor, JC; Allen, GP; Bearden, DT (October 2008). «Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.». Therapeutics and Clinical Risk Management 4 (5): 843–53. doi:10.2147/TCRM.S3426. PMID 19209267.
Morrissey, I.; Hoshino, K.; Sato, K.; Yoshida, A.; Hayakawa, I.; Bures, MG.; Shen, LL. (August 1996). «Mechanism of differential activities of ofloxacin enantiomers». Antimicrob Agents Chemother 40 (8): 1775–84. doi:10.1128/AAC.40.8.1775. PMID 8843280. PMC 163416. Αρχειοθετήθηκε από το πρωτότυπο στις 11 June 2011. https://web.archive.org/web/20110611220904/http://aac.asm.org/cgi/reprint/40/8/1775.pdf.

pubmedcentral.nih.gov

«Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults». Clin. Infect. Dis. 44 Suppl 2: S27–72. March 2007. doi:10.1086/511159. PMID 17278083.
«Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery». Cochrane Database Syst Rev 2: CD006364. 2017. doi:10.1002/14651858.CD006364.pub3. PMID 28192644.
«The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America». Clin. Infect. Dis. 53 (7): e25–76. 2011. doi:10.1093/cid/cir531. PMID 21880587.
«In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin». Antimicrob. Agents Chemother. 36 (4): 860–6. April 1992. doi:10.1128/aac.36.4.860. PMID 1503449. PMC 189464. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1992-04_36_4/page/860.
«Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone». Antimicrob. Agents Chemother. 41 (1): 204–11. January 1997. doi:10.1128/AAC.41.1.204. PMID 8980783. PMC 163688. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1997-01_41_1/page/204.
«Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding». Clin. Pharmacol. Ther. 84 (5): 581–8. November 2008. doi:10.1038/clpt.2008.150. PMID 18685566. PMC 2574587. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2008-11_84_5/page/581.
«Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide». Antimicrob. Agents Chemother. 37 (10): 2173–8. October 1993. doi:10.1128/aac.37.10.2173. PMID 8257141. PMC 192246. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_1993-10_37_10/page/2173.
Kim GK (April 2010). «The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?». J Clin Aesthet Dermatol 3 (4): 49–54. PMID 20725547.
«Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials». CMAJ 178 (7): 845–54. March 2008. doi:10.1503/cmaj.071157. PMID 18362380.
«DNA gyrase, topoisomerase IV, and the 4-quinolones». Microbiol Mol Biol Rev 61 (3): 377–92. 1 September 1997. doi:10.1128/.61.3.377-392.1997. PMID 9293187. PMC 232616. http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=9293187.
McGregor, JC; Allen, GP; Bearden, DT (October 2008). «Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.». Therapeutics and Clinical Risk Management 4 (5): 843–53. doi:10.2147/TCRM.S3426. PMID 19209267.
Morrissey, I.; Hoshino, K.; Sato, K.; Yoshida, A.; Hayakawa, I.; Bures, MG.; Shen, LL. (August 1996). «Mechanism of differential activities of ofloxacin enantiomers». Antimicrob Agents Chemother 40 (8): 1775–84. doi:10.1128/AAC.40.8.1775. PMID 8843280. PMC 163416. Αρχειοθετήθηκε από το πρωτότυπο στις 11 June 2011. https://web.archive.org/web/20110611220904/http://aac.asm.org/cgi/reprint/40/8/1775.pdf.

toxnet.nlm.nih.gov

«TOXNET: Levofloxacin». toxnet.nlm.nih.gov. U.S. National Library of Medicine. Ανακτήθηκε στις 16 Ιανουαρίου 2019.

oxfordjournals.org

jac.oxfordjournals.org

Domagala JM (April 1994). «Structure-activity and structure-side-effect relationships for the quinolone antibacterials». J. Antimicrob. Chemother. 33 (4): 685–706. doi:10.1093/jac/33.4.685. PMID 8056688. Αρχειοθετήθηκε από το πρωτότυπο στις 25 February 2009. https://web.archive.org/web/20090225032553/http://jac.oxfordjournals.org/cgi/reprint/33/4/685.

rero.ch

doc.rero.ch

«Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America». Clin. Infect. Dis. 56 (1): 1–10. January 2013. doi:10.1093/cid/cis966. PMID 23230301. http://doc.rero.ch/record/302350/files/cis966.pdf.

web.archive.org

«Levofloxacin». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Μαΐου 2016. Ανακτήθηκε στις 25 Αυγούστου 2016.
«Levofloxacin ophthalmic medical facts from Drugs.com». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Φεβρουαρίου 2017. Ανακτήθηκε στις 23 Ιανουαρίου 2017.
«US Label» (PDF). 2016. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 19 Σεπτεμβρίου 2016.
«FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling adverse effects that can occur». US Department of Health and Human Services. 25 Αυγούστου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Αυγούστου 2016.
ECDC (2014). «Antimicrobial resistance surveillance in Europe 2014» (PDF). Αρχειοθετήθηκε από το πρωτότυπο στις 14 Απριλίου 2016.
CDC. «Antibiotic Resistance Threats in the United States, 2013» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 17 Νοεμβρίου 2014.
Domagala JM (April 1994). «Structure-activity and structure-side-effect relationships for the quinolone antibacterials». J. Antimicrob. Chemother. 33 (4): 685–706. doi:10.1093/jac/33.4.685. PMID 8056688. Αρχειοθετήθηκε από το πρωτότυπο στις 25 February 2009. https://web.archive.org/web/20090225032553/http://jac.oxfordjournals.org/cgi/reprint/33/4/685.
«STATISTICAL REVIEW AND EVALUATION» (PDF). USA: FDA. 21 Νοεμβρίου 1996. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 18 Οκτωβρίου 2012.
Morrissey, I.; Hoshino, K.; Sato, K.; Yoshida, A.; Hayakawa, I.; Bures, MG.; Shen, LL. (August 1996). «Mechanism of differential activities of ofloxacin enantiomers». Antimicrob Agents Chemother 40 (8): 1775–84. doi:10.1128/AAC.40.8.1775. PMID 8843280. PMC 163416. Αρχειοθετήθηκε από το πρωτότυπο στις 11 June 2011. https://web.archive.org/web/20110611220904/http://aac.asm.org/cgi/reprint/40/8/1775.pdf.

worldcat.org

John A. Bosso (1998). «New and Emerging Quinolone Antibiotics». Journal of Infectious Disease Pharmacotherapy 2 (4): 61–76. doi:10.1300/J100v02n04_06. ISSN 1068-7777.